www.neurologiepropraxi.cz / Neurol. praxi. 2024;25(1):30-35 / NEUROLOGIE PRO PRAXI 35 HLAVNÍ TÉMA Creutzfeldtova‑Jakobova choroba v severnej časti stredného Slovenska: retrospektívna analýza súboru pacientov v rokoch 2006 až 2023 of Newborns in Slovakia. Pathogens. 2021;10(4):435. doi: 10.3390/pathogens10040435. 13. Kovacs GG, Seguin J, Quadrio I, et al. Genetic Creutzfeldt‑Jakob disease associated with the E200K mutation: characterization of a complex proteinopathy. Acta Neuropathol. 2011;121(1):39-57. doi: 10.1007/s00401010-0713-y. 14. Ladogana A, Kovacs GG. Genetic Creutzfeldt‑Jakob disease. Handb Clin Neurol. 2018, 153: 219-242. doi: 10.1016/ B978-0-444-63945-5.00013-1. 15. Lee HS, Sambuughin N, Cervenakova L, et al. Ancestral origins and worldwide distribution of the PRNP 200 K mutation causing familial Creutzfeldt‑Jakob disease. Am J Hum Genet. 1999;64(4):1063-70. doi: 10.1086/302340. 16. Lloyd SE, Mead S, Collinge J, et al. Genetics of prion diseases. Curr Opin Genet Dev. 2013;23(3):345-51. doi: 10.1016/j.gde.2013. 02. 012. 17. Mad’ar R, Maslenová D, Ranostajová K, et al. Analysis of unusual accumulation of Creutzfeldt‑Jakob disease cases in Orava and Liptov regions (northern Slovak focus) 1983-2000. Cent Eur J Public Health. 2003;11(1):19-22. 18. Manix M, Kalakoti P, Henry M, et al. Creutzfeldt‑Jakob disease: updated diagnostic criteria, treatment algorithm, and the utility of brain biopsy. Neurosurg Focus. 2015;39(5):E2. doi: 10.3171/2015. 8. FOCUS15328. 19. Mitrova E, Belay G. Creutzfeldt‑Jakob disease with E200K mutation in Slovakia: characterization and development. Acta Virol. 2002;46(1):31-9. 20. Mitrova E, Brown P, Hroncova D, et al. Focal Accumulation of Creutzfeldt‑Jakob Disease in Slovakia: retrospective investigation of a new rural familial cluster. Eur J Epidemiol. 1991;7(5):487-489. doi: 10.1007/BF00143126. 21. National Creutzfeldt‑Jakob Disease Research & Surveillance Unit (NCJDRSU). [cit. 27 April, 2020]. Available online: https://www.cjd.ed.ac.uk/sites/default/files/criteria_0.pdf. 22. Nishimura Y, Harada K, Koyama T, et al. A nationwide trend analysis in the incidence and mortality of Creutzfeldt ‑Jakob disease in Japan between 2005 and 2014. Sci Rep. 2020;10(1):15509. doi: 10.1038/s41598-020-72519-0. 23. Oliveira R, Dias M, Brás Marques I. Doença de Creutzfeldt ‑Jakob: Apresentação Atípica de uma Doença Muito Rara [Creutzfeldt‑Jakob Disease: Atypical Presentation of a Very Rare Disease]. Acta Med Port. 2021;34(9):619-623. doi: 10.20344/ amp.13117. 24. Slivarichová D, Mitrová E, Ursínyová M, et al. Geographic accumulation of Creutzfeldt‑Jakob disease in Slovakia – environmental metal imbalance as a possible cofactor. Cent Eur J Public Health. 2011;19(3):158-64. doi: 10.21101/cejph.a3667. 25. Uttley L, Carroll C, Wong R, et al. Creutzfeldt‑Jakob disease: a systematic review of global incidence, prevalence, infectivity, and incubation. Lancet Infect, DiS. 2020;20(1):e2-e10. doi: 10.1016/S1473-3099(19)30615-2. 26. Vakilian A, Fekri M, Farahmand H. Creutzfeldt‑Jakob Disease Presenting with Dementia and Mimic a Stroke During One Year: Case Report and Review of Literatures. Galen Med J. 2019;1;8:e1357. doi: 10.31661/gmj.v8i0.1357. 27. Xu Z, Zhao Y. A Creutzfeldt‑Jakob disease case misdiagnosed with acute cerebral infarction and review of the literature. Clin Case Rep. 2020;19;8(12):3311-3315. doi: 10.1002/ ccr3.3388. ODBORNÝ GARANT: MUDr. Stanislav Voháňka, CSc., MBA POŘADATEL: Společnost SOLEN, s. r. o., ve spolupráci s Neurologickou klinikou LF MU a FN Brno, Neuromuskulárním centrem ERN POČET KREDITŮ 2 Registrace ZDARMA TERMÍN listopad 2023 až říjen 2024 dostupný na online.solen.cz Úskalí klasické imunosupresivní léčby ON LINE KURZ OBSAH KURZU Současná a nová léčba myastenie gravis: praxe a výzvy MUDr. Stanislav Voháňka, CSc., MBA, MUDr. Magda Horáková Eculizumab v terapii thymom-asociované myastenie MUDr. Magda Horáková, MUDr. Viktória Kokošová, prof. MUDr. Josef Bednařík, CSc., MUDr. Stanislav Voháňka, CSc., MBA Kazuistika k diskuzi – MUDr. Michaela Týblová, Ph.D. Farmakorezistentní myastenik s thymomem – MUDr. Jana Junkerová Novinky v léčbě myasthenia gravis – MUDr. Michaela Týblová, Ph.D.
RkJQdWJsaXNoZXIy NDA4Mjc=